Ginsenoside Rg3: A Review of Its Anticancer Mechanisms and Potential Therapeutic Applications

Overview

Journal Curr Top Med Chem

Publisher Bentham Science Publishers

Specialty Chemistry

Date 2024 Mar 5

PMID 38441023

Authors

Lei Wu

Lin Bai

Wenshu Dai

Yaping Wu

Pengjun Xi

Jie Zhang

Lily Zheng

Affiliations

Soon will be listed here.

Abstract

Background: Traditional Chinese Medicine (TCM) has a long history of treating various diseases and is increasingly being recognized as a complementary therapy for cancer. A promising natural compound extracted from the Chinese herb ginseng is ginsenoside Rg3, which has demonstrated significant anticancer effects. It has been tested in a variety of cancers and tumors and has proven to be effective in suppressing cancer.

Objectives: This work covers various aspects of the role of ginsenoside Rg3 in cancer treatment, including its biological functions, key pathways, epigenetics, and potential for combination therapies, all of which have been extensively researched and elucidated. The study aims to provide a reference for future research on ginsenoside Rg3 as an anticancer agent and a support for the potential application of ginsenoside Rg3 in cancer treatment.

Citing Articles

Anti-colorectal cancer effect of total minor ginsenosides produced by lactobacilli transformation of major ginsenosides by inducing apoptosis and regulating gut microbiota.

Shen Y, Gao Y, Yang G, Zhao Z, Zhao Y, Gao L Front Pharmacol. 2025; 15():1496346.

PMID: 39845805 PMC: 11750747. DOI: 10.3389/fphar.2024.1496346.

Changes in the chemical composition and medicinal effects of black ginseng during processing.

Qiu Y, Wang N, Yu Z, Guo X, Yang M Front Pharmacol. 2024; 15:1425794.

PMID: 39588153 PMC: 11586192. DOI: 10.3389/fphar.2024.1425794.

References

Wang H, Xu F, Wang X, Kwon W, Yang D . Molecular discrimination of cultivar K-1 using pathogenesis-related protein 5 gene. J Ginseng Res. 2019; 43(3):482-487. PMC: 6606972. DOI: 10.1016/j.jgr.2018.07.001. View

Mohanan P, Subramaniyam S, Mathiyalagan R, Yang D . Molecular signaling of ginsenosides Rb1, Rg1, and Rg3 and their mode of actions. J Ginseng Res. 2018; 42(2):123-132. PMC: 5926405. DOI: 10.1016/j.jgr.2017.01.008. View

Zhang H, Abid S, Ahn J, Mathiyalagan R, Kim Y, Yang D . Characteristics of Cultivars in Korea and China. Molecules. 2020; 25(11). PMC: 7321059. DOI: 10.3390/molecules25112635. View

Kwon Y, Jang S, Liu K, Jung D . Effect of Korean Red Ginseng on Cholesterol Metabolites in Postmenopausal Women with Hypercholesterolemia: A Pilot Randomized Controlled Trial. Nutrients. 2020; 12(11). PMC: 7695162. DOI: 10.3390/nu12113423. View

Chung S, Nam S, Xu M, Kang M, Lee S . Aged ginseng ( Meyer) reduces blood glucose levels and improves lipid metabolism in high fat diet-fed mice. Food Sci Biotechnol. 2018; 25(1):267-273. PMC: 6049365. DOI: 10.1007/s10068-016-0039-1. View

Jeon B, Kim C, Park K, Lee J, Park J, Kim K . Effect of Korea red ginseng on the blood pressure in conscious hypertensive rats. Gen Pharmacol. 2001; 35(3):135-41. DOI: 10.1016/s0306-3623(01)00096-9. View

Baek K, Yi Y, Son Y, Yoo S, Sung N, Kim Y . and anti-inflammatory activities of Korean Red Ginseng-derived components. J Ginseng Res. 2016; 40(4):437-444. PMC: 5052440. DOI: 10.1016/j.jgr.2016.08.003. View

Surh Y, Na H, Lee J, Keum Y . Molecular mechanisms underlying anti-tumor promoting activities of heat-processed Panax ginseng C.A. Meyer. J Korean Med Sci. 2001; 16 Suppl:S38-41. PMC: 3202206. DOI: 10.3346/jkms.2001.16.S.S38. View

Sun X, Matsumoto T, Yamada H . Anti-ulcer activity and mode of action of the polysaccharide fraction from the leaves of Panax ginseng. Planta Med. 1992; 58(5):432-5. DOI: 10.1055/s-2006-961507. View

10.

Chung S, Kang M, Lee S . In Vitro and In Vivo Antioxidant Activity of Aged Ginseng (Panax ginseng). Prev Nutr Food Sci. 2016; 21(1):24-30. PMC: 4827631. DOI: 10.3746/pnf.2016.21.1.24. View

11.

Fan W, Fan L, Wang Z, Mei Y, Liu L, Li L . Rare ginsenosides: A unique perspective of ginseng research. J Adv Res. 2024; 66:303-328. PMC: 11674801. DOI: 10.1016/j.jare.2024.01.003. View

12.

Lu J, Yao Q, Chen C . Ginseng compounds: an update on their molecular mechanisms and medical applications. Curr Vasc Pharmacol. 2009; 7(3):293-302. PMC: 2928028. DOI: 10.2174/157016109788340767. View

13.

Shin B, Kwon S, Park J . Chemical diversity of ginseng saponins from Panax ginseng. J Ginseng Res. 2016; 39(4):287-98. PMC: 4593792. DOI: 10.1016/j.jgr.2014.12.005. View

14.

Chopra P, Chhillar H, Kim Y, Jo I, Kim S, Gupta R . Phytochemistry of ginsenosides: Recent advancements and emerging roles. Crit Rev Food Sci Nutr. 2021; 63(5):613-640. DOI: 10.1080/10408398.2021.1952159. View

15.

Zhou P, Xie W, He S, Sun Y, Meng X, Sun G . Ginsenoside Rb1 as an Anti-Diabetic Agent and Its Underlying Mechanism Analysis. Cells. 2019; 8(3). PMC: 6468558. DOI: 10.3390/cells8030204. View

16.

Joh E, Lee I, Jung I, Kim D . Ginsenoside Rb1 and its metabolite compound K inhibit IRAK-1 activation--the key step of inflammation. Biochem Pharmacol. 2011; 82(3):278-86. DOI: 10.1016/j.bcp.2011.05.003. View

17.

Lee Y, Jin Y, Lim W, Park W, Cho J, Jang S . Ginsenoside-Rb1 acts as a weak phytoestrogen in MCF-7 human breast cancer cells. Arch Pharm Res. 2003; 26(1):58-63. DOI: 10.1007/BF03179933. View

18.

Lee D, Jang S, Kim Y, Yang K, Yoon S, Lee Z . Anti-proliferative effects of ginsenosides extracted from mountain ginseng on lung cancer. Chin J Integr Med. 2014; 22(5):344-52. DOI: 10.1007/s11655-014-1789-8. View

19.

Li Y, He F, Zhang Y, Pan Z . Apatinib and Ginsenoside-Rb1 Synergetically Control the Growth of Hypopharyngeal Carcinoma Cells. Dis Markers. 2022; 2022:3833489. PMC: 8776476. DOI: 10.1155/2022/3833489. View

20.

Zhang J, Wang J, Wu X, Wei Y . Ginsenoside Rb1 inhibits proliferation and promotes apoptosis by regulating HMGB1 in uterine fibroid cells. Artif Cells Nanomed Biotechnol. 2019; 47(1):2967-2971. DOI: 10.1080/21691401.2019.1643732. View